BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24216689)

  • 21. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Cars T; Wettermark B; Löfberg R; Eriksson I; Sundström J; Lördal M
    J Crohns Colitis; 2016 May; 10(5):556-65. PubMed ID: 26733406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study.
    Singh H; Nugent Z; Demers AA; Bernstein CN
    Inflamm Bowel Dis; 2011 Aug; 17(8):1741-50. PubMed ID: 21744429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-Wide Study: Exploring Medication Use 10 Years Before a Diagnosis of Inflammatory Bowel Disease.
    Bonfils L; Karachalia Sandri A; Poulsen GJ; Agrawal M; Ward DJ; Colombel JF; Jess T; Allin KH
    Am J Gastroenterol; 2023 Dec; 118(12):2220-2229. PubMed ID: 37410928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
    Tiao DK; Chan W; Jeganathan J; Chan JT; Perry J; Selinger CP; Leong RW
    Inflamm Bowel Dis; 2017 Aug; 23(8):1257-1261. PubMed ID: 28719539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant use among paediatric patients with recent-onset inflammatory bowel disease: a nationwide case control study in Finland.
    Virta LJ; Kolho KL
    J Paediatr Child Health; 2014 Jul; 50(7):562-5. PubMed ID: 24612280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
    Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study.
    Goodhand JR; Greig FI; Koodun Y; McDermott A; Wahed M; Langmead L; Rampton DS
    Inflamm Bowel Dis; 2012 Jul; 18(7):1232-9. PubMed ID: 22234954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
    Kappelman MD; Rifas-Shiman SL; Porter CQ; Ollendorf DA; Sandler RS; Galanko JA; Finkelstein JA
    Gastroenterology; 2008 Dec; 135(6):1907-13. PubMed ID: 18854185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Targownik LE; Kaplan GG; Witt J; Bernstein CN; Singh H; Tennakoon A; Aviña Zubieta A; Coward SB; Jones J; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN; Benchimol EI
    Am J Gastroenterol; 2020 Jan; 115(1):128-137. PubMed ID: 31895723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription trajectories and effect of total hip arthroplasty on the use of analgesics, hypnotics, antidepressants, and anxiolytics: results from a population of total hip arthroplasty patients.
    Blågestad T; Nordhus IH; Grønli J; Engesæter LB; Ruths S; Ranhoff AH; Bjorvatn B; Pallesen S
    Pain; 2016 Mar; 157(3):643-651. PubMed ID: 26588693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between spring season of birth and Crohn's disease.
    Shaw SY; Nugent Z; Targownik LE; Singh H; Blanchard JF; Bernstein CN
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):277-82. PubMed ID: 23924874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.
    Lenti MV; Selinger CP
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):215-226. PubMed ID: 28099821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
    Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.
    Herrinton LJ; Liu L; Lafata JE; Allison JE; Andrade SE; Korner EJ; Chan KA; Platt R; Hiatt D; O'Connor S
    Inflamm Bowel Dis; 2007 Apr; 13(4):451-61. PubMed ID: 17219403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct medical cost of managing IBD patients: a Canadian population-based study.
    Bernstein CN; Longobardi T; Finlayson G; Blanchard JF
    Inflamm Bowel Dis; 2012 Aug; 18(8):1498-508. PubMed ID: 22109958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure.
    Jiang Y; Lin O; Sinha SR
    Dig Dis Sci; 2017 Jun; 62(6):1597-1606. PubMed ID: 28417241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
    Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
    Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current health status and medical therapy of patients with pediatric-onset inflammatory bowel disease: a survey-based analysis on 1280 patients aged 10-25 years focusing on differences by age of onset.
    Timmer A; Stark R; Peplies J; Classen M; Laass MW; Koletzko S
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1276-1283. PubMed ID: 28877085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease.
    Vavricka SR; Schoepfer AM; Safroneeva E; Rogler G; Schwenkglenks M; Achermann R
    Inflamm Bowel Dis; 2013; 19(4):840-6. PubMed ID: 23429462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.